Skip to content

A clinical trial to study the effects of haridra dhupan in shawasa

A RANDOMIZED CONTROLLED CLINICAL STUDY OF EFFICACY OF HARIDRA DHUPAN IN THAMAK SHWASA VEGAWASTHA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075754
Enrollment
30
Registered
2024-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma Health Condition 2: J454- Moderate persistent asthma

Interventions

Intervention1: Drug classical: Medicine named haridra reference bhavprakash nighantu route inhalation dose 10g frequency sos bhasjya kal sos Intervention2: Drug classical: Medicine named haridra refer

Sponsors

Dr Pushpa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with tamak shawas vegawastha/Bronchial Asthma

Exclusion criteria

Exclusion criteria: Patients having acute exacerbation of asthma at the time of registration Patients having severe persistent asthma as per GINA classification Patients having tuberculosis pneumonia bronchiectasis and SPO2 5 80% Patient having history of any hypersensitivity to any of the ingredient/s of the trial drugs Patients having history of malignancy Hematemesis,on immunotherapy and having any other concomitant systemic illness which required immediate medical intervention Patients receiving Steroid/ Broncho dilator (orally/inhaled) in last 6 hours Pregnant and lactating mothers Patients having bronchial asthma more than 5 years

Design outcomes

Primary

MeasureTime frame
To determine the effect of Haridra Dhupan in improving lung function such as PEFR FEV1 FVC To determine the effect of Haridra Dhupan in improving asthma symptoms and reducing the severity of tamak swasa vegawasthaTimepoint: 5-7 minutes

Secondary

MeasureTime frame
To study the effect of Haridra Dhupan on nasal symptoms score To determine the safety of Haridra Dhupan in patients of Tamak Shwasa To determine the effect of Haridra Dhupan in Improving SPO2 oxygen saturationTimepoint: 5-7 minutes

Countries

India

Contacts

Public ContactDr Parshuram Dongare

Government Ayurvedic College , Nanded Maharashtra

dongarepd@gmail.com8295686601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026